T细胞白血病前T细胞受体作为肿瘤免疫治疗靶点

IF 27.6 1区医学 Q1 IMMUNOLOGY

Nature Immunology Pub Date : 2025-09-05 DOI:10.1038/s41590-025-02269-6

Aliza Rosen, Iannis Aifantis

引用次数: 0

摘要

T细胞前受体对T细胞的发育至关重要。它也是一种新兴的免疫治疗靶点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

The pre-T cell receptor as a tumor immunotherapy target in T cell leukemia

查看原文本刊更多论文

The pre-T cell receptor as a tumor immunotherapy target in T cell leukemia

The pre-T cell receptor is essential for T cell development. It is also an emerging immunotherapy target.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Immunology 医学-免疫学

CiteScore

40.00

自引率

2.30%

发文量

248

审稿时长

4-8 weeks

期刊介绍： Nature Immunology is a monthly journal that publishes the highest quality research in all areas of immunology. The editorial decisions are made by a team of full-time professional editors. The journal prioritizes work that provides translational and/or fundamental insight into the workings of the immune system. It covers a wide range of topics including innate immunity and inflammation, development, immune receptors, signaling and apoptosis, antigen presentation, gene regulation and recombination, cellular and systemic immunity, vaccines, immune tolerance, autoimmunity, tumor immunology, and microbial immunopathology. In addition to publishing significant original research, Nature Immunology also includes comments, News and Views, research highlights, matters arising from readers, and reviews of the literature. The journal serves as a major conduit of top-quality information for the immunology community.